1. Home
  2. AMSC vs DNTH Comparison

AMSC vs DNTH Comparison

Compare AMSC & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMSC
  • DNTH
  • Stock Information
  • Founded
  • AMSC 1987
  • DNTH 2015
  • Country
  • AMSC United States
  • DNTH United States
  • Employees
  • AMSC N/A
  • DNTH N/A
  • Industry
  • AMSC Metal Fabrications
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMSC Consumer Discretionary
  • DNTH Health Care
  • Exchange
  • AMSC Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • AMSC 616.8M
  • DNTH 565.7M
  • IPO Year
  • AMSC 1991
  • DNTH N/A
  • Fundamental
  • Price
  • AMSC $18.41
  • DNTH $19.50
  • Analyst Decision
  • AMSC Strong Buy
  • DNTH Strong Buy
  • Analyst Count
  • AMSC 3
  • DNTH 8
  • Target Price
  • AMSC $33.67
  • DNTH $54.33
  • AVG Volume (30 Days)
  • AMSC 626.5K
  • DNTH 418.5K
  • Earning Date
  • AMSC 05-28-2025
  • DNTH 05-08-2025
  • Dividend Yield
  • AMSC N/A
  • DNTH N/A
  • EPS Growth
  • AMSC N/A
  • DNTH N/A
  • EPS
  • AMSC 0.09
  • DNTH N/A
  • Revenue
  • AMSC $198,191,000.00
  • DNTH $6,235,000.00
  • Revenue This Year
  • AMSC $51.58
  • DNTH N/A
  • Revenue Next Year
  • AMSC $16.67
  • DNTH N/A
  • P/E Ratio
  • AMSC $203.16
  • DNTH N/A
  • Revenue Growth
  • AMSC 46.42
  • DNTH 120.63
  • 52 Week Low
  • AMSC $11.36
  • DNTH $13.37
  • 52 Week High
  • AMSC $38.02
  • DNTH $32.27
  • Technical
  • Relative Strength Index (RSI)
  • AMSC 46.79
  • DNTH 53.31
  • Support Level
  • AMSC $17.58
  • DNTH $18.37
  • Resistance Level
  • AMSC $18.78
  • DNTH $19.76
  • Average True Range (ATR)
  • AMSC 1.55
  • DNTH 1.93
  • MACD
  • AMSC 0.31
  • DNTH 0.45
  • Stochastic Oscillator
  • AMSC 82.65
  • DNTH 95.93

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet world's demand for smarter, cleaner and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: